Estimaciones de analistas de Wall Street para Scholar Rock Holding Corporation (SRRK): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 12 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 12 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.87 | ||
| 2026-08-06 | $-0.84 | $-0.84 | +0.1% |
| 2026-05-07 | $-0.83 | $-0.82 | -1.2% |
| 2026-03-03 | $-0.88 | $-0.88 | +0.3% |
| 2025-11-14 | $-0.90 | $-0.84 | -7.8% |
| 2025-08-06 | $-0.98 | $-0.66 | -48.5% |
| 2025-05-14 | $-0.67 | $-0.63 | -6.3% |
| 2025-02-27 | $-0.60 | $-0.60 | +0.0% |
Ratios de valoración
| Precio / Valor contable | 22.93 |
| EV / EBITDA | -14.53 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $379000 | 0 | 0 | $20.5M | $15.4M | $18.8M | $33.2M | 0 | 0 | 0 |
| Coste de Ventas | $12.5M | $669000 | $807000 | $54.2M | $74.1M | $108.5M | $123.0M | $2.8M | $1.9M | $208.4M |
| Beneficio Bruto | -$12.1M | -$669000 | -$807000 | -$33.7M | -$58.7M | -$89.7M | -$89.9M | -$2.8M | -$1.9M | -$208.4M |
| I+D | $12.5M | $19.9M | $36.3M | $54.2M | $74.1M | $108.5M | $124.4M | $119.1M | $182.6M | $208.4M |
| Generales y Administrativos | $4.1M | $5.1M | $14.4M | $20.8M | $28.2M | $40.3M | $42.6M | $49.4M | $67.5M | $176.2M |
| Gastos Operativos | $16.6M | $25.0M | $50.7M | $20.8M | $28.2M | $40.3M | $44.5M | $168.5M | $250.1M | $176.2M |
| Beneficio Operativo | -$16.2M | -$25.0M | -$50.7M | -$54.5M | -$86.9M | -$129.9M | -$134.4M | -$171.3M | -$252.1M | -$384.6M |
| EBITDA | -$15.6M | -$24.4M | -$49.9M | -$53.2M | -$85.4M | -$129.2M | -$129.5M | -$162.9M | -$237.5M | -$369.4M |
| Gastos por Intereses | $19000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $6.8M | $6.9M |
| Beneficio Antes de Impuestos | -$16.2M | -$25.0M | -$49.3M | -$51.0M | -$86.5M | -$131.8M | -$134.5M | -$165.8M | -$246.3M | -$377.9M |
| Impuestos | $19000 | -$44000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$16.2M | -$25.0M | -$49.3M | -$51.0M | -$86.5M | -$131.8M | -$134.5M | -$165.8M | -$246.3M | -$377.9M |
| BPA | $-0.91 | $-1.40 | $-3.15 | $-1.80 | $-2.77 | $-3.59 | $-2.21 | $-1.99 | $-2.47 | $-3.29 |
| BPA Diluido | $-0.91 | $-1.40 | $-3.15 | $-1.80 | $-2.77 | $-3.59 | $-2.21 | $-1.99 | $-2.47 | $-3.29 |
| Acciones en Circulación (Diluidas) | $17.9M | $17.9M | $15.7M | $27.5M | $30.7M | $36.7M | $59.6M | $76.0M | $99.8M | $114.7M |
Precio
| Precio | $49.37 |
| Capitalización | $5.9B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADPT · BEAM · CDTX · IDYA · IRON · KNSA · LEGN
Explorar sector: Healthcare · Biotechnology
Más secciones de SRRK: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones